Eli Lilly's CFO Plans To Retire -- WSJ

By Imani Moise Features Dow Jones Newswires

Eli Lilly & Co. said Thursday that longtime Chief Financial Officer Derica Rice will retire at the end of this year after more than a decade in the position.

Continue Reading Below

Mr. Rice, who has spent 27 years at the pharmaceutical company, also is a member of Lilly's executive committee.

"Derica has been a core part of Lilly's turnaround, our innovation strategy and our consistent ability to set and then meet targets and commitments," said David Ricks, Lilly chairman, president and chief executive.

Lilly is considering internal and external candidates to succeed Mr. Rice, who joined the company in 1990. He was promoted to his current role in May 2006 and had a brief stint as interim CEO while John Lechleiter was on medical leave in 2013. Mr. Lechleiter announced his retirement last year.

Lilly's recent financial results have been helped by manufacturing efficiencies and stronger sales, but the company swung to a loss in its latest quarter owing to charges related to cost-cutting efforts.

Lilly shares edged 0.1% higher during morning trading and have gained 53% over the past 11 years.

Continue Reading Below

Write to Imani Moise at imani.moise@wsj.com

Corrections & Amplifications John Lechleiter announced his retirement last year. An earlier version of this article misspelled the last name of the former chief executive. (June 1, 2017)

(END) Dow Jones Newswires

June 02, 2017 02:47 ET (06:47 GMT)